These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 8084119)

  • 21. [Agents for the metabolic correction of myocardial energy metabolism in treating patients with ischemic heart disease].
    Vizyr AD; Kraĭdashenko OV; Berezin OIe; Oliĭnyk OI
    Lik Sprava; 2000 Mar; (2):26-30. PubMed ID: 10862469
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hemodynamics and exercise tolerance after bisoprolol, nifedipine, and their combination in patients with angina pectoris.
    Schnellbacher K; Bestehorn HP; Roskamm H
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S201-7. PubMed ID: 11527130
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Uric-acid reduction with high allopurinol dosages (author's transl)].
    Mertz DP; Loewer H
    Dtsch Med Wochenschr; 1979 Mar; 104(9):324-5. PubMed ID: 761542
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The effect of allopurinol on hemodynamic, respiratory and biochemical functional values in health persons following oral administration].
    Sziegoleit W; Terhaag B; Taube C; Förster W
    Int J Clin Pharmacol Biopharm; 1975 Dec; 12(4):408-18. PubMed ID: 1205655
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The effect of transvenous laser therapy on lipid peroxidation function in patients with ischemic heart disease].
    Vakhliaev VD; Smirnova IE; Uchaĭkina LV; Barsel' VA; Aksiutina MS; Matveeva SA; Paramonova MA; Shchedrina IS; Syrkin AL
    Kardiologiia; 1992 Jul; 32(7-8):43-5. PubMed ID: 1487878
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The efficacy of combined low dose of Allopurinol and benzbromarone compared to standard dose of Allopurinol in hyperuricemia.
    Akkasilpa S; Osiri M; Deesomchok U; Avihingsanon Y
    J Med Assoc Thai; 2004 Sep; 87(9):1087-91. PubMed ID: 15516011
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effects of metabolic therapy on intracellular level of antioxidant system in elderly patients with ischemic heart disease].
    Kalinina EV; Komissarova IA; Zaslavskaia RM; Novichkova MD; Kelimberdieva ES
    Klin Med (Mosk); 2000; 78(1):40-3. PubMed ID: 10697374
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Angina pectoris].
    Vagueiro MC
    Minerva Med; 1976 Dec; 67(61):4045-51. PubMed ID: 826855
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Correlation between severity of angina, its stability, and oxidative modification of lipids in patients with ischemic heart disease].
    Syrkin AL; Azizov OA; Drinitsina SV; Frenkel' EE; Solov'eva NP; Dudnik LB; Kliuchnikova TI
    Ter Arkh; 2001; 73(9):38-42. PubMed ID: 11642079
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effect of prolonged-action pentaerythritol treatment in angina pectoris. Study base on its effects on the modifications of the electrocardiogram induced by the effort test].
    Vedoya R; Nessi CT; Papakis ME; Gaguine S
    Prensa Med Argent; 1966 Jul; 53(27):1468-79. PubMed ID: 5990480
    [No Abstract]   [Full Text] [Related]  

  • 31. [The effect of antianginal preparations on the hemodynamics and metabolism of the ischemic myocardium].
    Makolkin VI; Vakhliaev VD
    Eksp Klin Farmakol; 1996; 59(4):18-20. PubMed ID: 9026181
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of allopurinol, a xanthine oxidase inhibitor, on renal injury in hypercholesterolemia-induced hypertensive rats.
    Minami M; Ishiyama A; Takagi M; Omata M; Atarashi K
    Blood Press; 2005; 14(2):120-5. PubMed ID: 16036490
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Treatment of coronary angina. Use of a delayed-action nitrate derivative].
    Giard
    J Sci Med Lille; 1972 Nov; 90(11):407-10. PubMed ID: 4650213
    [No Abstract]   [Full Text] [Related]  

  • 34. [Long lasting normalization of uric acid after combination therapy with 300 mg allopurinol and 60 mg benzbromarone in patients with gout and hyperuricemia].
    Matzkies F
    Med Klin (Munich); 1992 Sep; 87(9):460-2. PubMed ID: 1406482
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effect of the treatment with fenigidin on peripheral hemodynamics in patients with stable angina pectoris].
    Boev SS
    Lik Sprava; 2003; (7):98-100. PubMed ID: 14723149
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level.
    Siu YP; Leung KT; Tong MK; Kwan TH
    Am J Kidney Dis; 2006 Jan; 47(1):51-9. PubMed ID: 16377385
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Blood antioxidants and indices of lipid peroxidation in subjects with angina pectoris.
    Duthie GG; Beattie JA; Arthur JR; Franklin M; Morrice PC; James WP
    Nutrition; 1994; 10(4):313-6. PubMed ID: 8000152
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Comparison of the effect of nitroglycerine and pentaerithritol compositum on exercise time restricted by anginal pain or objective parameters of ischaemia in patients with stable angina].
    Siński M; Lewandowski J; Abramczyk P; Nowosad H; Grzelak-Szafrańiska H
    Pol Arch Med Wewn; 2005 Aug; 114(2):755-60. PubMed ID: 16808313
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical and metabolic effects of betaxolol (lokren) in treatment of patients with chronic cardiac insufficiency].
    Korzh AN
    Lik Sprava; 2003; (5-6):90-2. PubMed ID: 14618815
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Allopurinol use yields potentially beneficial effects on inflammatory indices in those with recent ischemic stroke: a randomized, double-blind, placebo-controlled trial.
    Muir SW; Harrow C; Dawson J; Lees KR; Weir CJ; Sattar N; Walters MR
    Stroke; 2008 Dec; 39(12):3303-7. PubMed ID: 18845806
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.